{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:19:23Z","timestamp":1772619563631,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many hemorheologic Traditional Chinese Medicines (TCMs) that are widely-used clinically lack molecular mechanisms of action. We hypothesized that some of the active components of hemorheologic TCMs may function through targeting prothrombotic P2Y<jats:sub>1<\/jats:sub> and\/or P2Y<jats:sub>12<\/jats:sub> receptors. The interactions between 253 antithrombotic compounds from TCM and these two G protein-coupled P2Y receptors were evaluated using virtual screening. Eleven highly ranked hits were further tested in radioligand binding and functional assays. Among these compounds, salvianolic acid A and C antagonized the activity of both P2Y<jats:sub>1<\/jats:sub> and P2Y<jats:sub>12<\/jats:sub> receptors in the low \u00b5M range, while salvianolic acid B antagonized the P2Y<jats:sub>12<\/jats:sub> receptor. These three salvianolic acids are the major active components of the broadly-used hemorheologic TCM Danshen (<jats:italic>Salvia militorrhiza<\/jats:italic>), the antithrombotic molecular mechanisms of which were largely unknown. Thus, the combination of virtual screening and experimental validation identified potential mechanisms of action of multicomponent drugs that are already employed clinically.<\/jats:p>","DOI":"10.1038\/s41598-018-26577-0","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T09:34:14Z","timestamp":1526636054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors"],"prefix":"10.1038","volume":"8","author":[{"given":"Xuyang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan-Guo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4522-8725","authenticated-orcid":false,"given":"Raymond C.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-1493","authenticated-orcid":false,"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-434X","authenticated-orcid":false,"given":"Suwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"26577_CR1","doi-asserted-by":"publisher","first-page":"2430329","DOI":"10.1155\/2016\/2430329","volume":"2016","author":"M Guo","year":"2016","unstructured":"Guo, M., Liu, Y. & Shi, D. Cardiovascular Actions and Therapeutic Potential of Tetramethylpyrazine (Active Component Isolated from Rhizoma Chuanxiong): Roles and Mechanisms. Biomed Res Int 2016, 2430329, https:\/\/doi.org\/10.1155\/2016\/2430329 (2016).","journal-title":"Biomed Res Int"},{"key":"26577_CR2","doi-asserted-by":"publisher","unstructured":"Yufei, F. Analysis of Salvia miltiorrhiza (Danshen). African Journal of Microbiology Research 6, https:\/\/doi.org\/10.5897\/ajmr11.1256 (2012).","DOI":"10.5897\/ajmr11.1256"},{"key":"26577_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jep.2015.08.033","volume":"175","author":"ZZ Duan","year":"2015","unstructured":"Duan, Z. Z. et al. Danhong injection protects cardiomyocytes against hypoxia\/reoxygenation- and H2O2-induced injury by inhibiting mitochondrial permeability transition pore opening. J Ethnopharmacol 175, 617\u2013625, https:\/\/doi.org\/10.1016\/j.jep.2015.08.033 (2015).","journal-title":"J Ethnopharmacol"},{"key":"26577_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/aps.2012.126","volume":"33","author":"WY Wu","year":"2012","unstructured":"Wu, W. Y. & Wang, Y. P. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacol Sin 33, 1119\u20131130, https:\/\/doi.org\/10.1038\/aps.2012.126 (2012).","journal-title":"Acta Pharmacol Sin"},{"key":"26577_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.talanta.2005.09.041","volume":"69","author":"JH Chen","year":"2006","unstructured":"Chen, J. H., Wang, F. M., Lee, F. S. C., Wang, X. R. & Xie, M. Y. Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis. Talanta 69, 172\u2013179, https:\/\/doi.org\/10.1016\/j.talanta.2005.09.041 (2006).","journal-title":"Talanta"},{"key":"26577_CR6","doi-asserted-by":"publisher","first-page":"e0170182","DOI":"10.1371\/journal.pone.0170182","volume":"12","author":"YY Yan","year":"2017","unstructured":"Yan, Y. Y. et al. Post-Marketing Safety Surveillance of the Salvia Miltiorrhiza Depside Salt for Infusion: A Real World Study. PLoS One 12, e0170182, https:\/\/doi.org\/10.1371\/journal.pone.0170182 (2017).","journal-title":"PLoS One"},{"key":"26577_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0254-6272(15)30091-1","volume":"34","author":"Y Chang","year":"2014","unstructured":"Chang, Y. et al. Postmarketing safety evaluation: depside salt injection made from Danshen (Radix Salviae Miltiorrhizae). J Tradit Chin Med 34, 749\u2013753 (2014).","journal-title":"J Tradit Chin Med"},{"key":"26577_CR8","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.thromres.2010.04.006","volume":"126","author":"HY Fan","year":"2010","unstructured":"Fan, H. Y. et al. Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb Res 126, e17\u201322, https:\/\/doi.org\/10.1016\/j.thromres.2010.04.006 (2010).","journal-title":"Thromb Res"},{"key":"26577_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jpba.2015.06.009","volume":"117","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. A Platelet\/CMC coupled with offline UPLC-QTOF-MS\/MS for screening antiplatelet activity components from aqueous extract of Danshen. J Pharm Biomed Anal 117, 178\u2013183, https:\/\/doi.org\/10.1016\/j.jpba.2015.06.009 (2016).","journal-title":"J Pharm Biomed Anal"},{"key":"26577_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.thromres.2014.07.019","volume":"134","author":"L Liu","year":"2014","unstructured":"Liu, L. et al. Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory. Thromb Res 134, 866\u2013876, https:\/\/doi.org\/10.1016\/j.thromres.2014.07.019 (2014).","journal-title":"Thromb Res"},{"key":"26577_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1423-0127-18-30","volume":"18","author":"JH Ho","year":"2011","unstructured":"Ho, J. H. & Hong, C. Y. Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection. J Biomed Sci 18, 30, https:\/\/doi.org\/10.1186\/1423-0127-18-30 (2011).","journal-title":"J Biomed Sci"},{"key":"26577_CR12","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","volume":"95","author":"JG Jin","year":"1998","unstructured":"Jin, J. G. & Kunapuli, S. P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc. Natl. Acad. Sci. USA 95, 8070\u20138074, https:\/\/doi.org\/10.1073\/pnas.95.14.8070 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"26577_CR13","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/blood-2004-07-2893","volume":"105","author":"AR Hardy","year":"2005","unstructured":"Hardy, A. R. et al. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105, 3552\u20133560, https:\/\/doi.org\/10.1182\/blood-2004-07-2893 (2005).","journal-title":"Blood"},{"key":"26577_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1161\/01.RES.0000251742.71301.16","volume":"99","author":"S Offermanns","year":"2006","unstructured":"Offermanns, S. Activation of platelet function through G protein-coupled receptors. Circ Res 99, 1293\u20131304, https:\/\/doi.org\/10.1161\/01.RES.0000251742.71301.16 (2006).","journal-title":"Circ Res"},{"key":"26577_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/FPC.0b013e3283406323","volume":"21","author":"K Sangkuhl","year":"2011","unstructured":"Sangkuhl, K., Shuldiner, A. R., Klein, T. E. & Altman, R. B. Platelet aggregation pathway. Pharmacogenet Genomics 21, 516\u2013521, https:\/\/doi.org\/10.1097\/FPC.0b013e3283406323 (2011).","journal-title":"Pharmacogenet Genomics"},{"key":"26577_CR16","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1182\/blood.V98.12.3340","volume":"98","author":"NA Turner","year":"2001","unstructured":"Turner, N. A., Moake, J. L. & McIntire, L. V. Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow. Blood 98, 3340\u20133345 (2001).","journal-title":"Blood"},{"key":"26577_CR17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/sj.bjp.0705885","volume":"142","author":"S Nylander","year":"2004","unstructured":"Nylander, S., Mattsson, C., Ramstrom, S. & Lindahl, T. L. Synergistic action between inhibition of P2Y12\/P2Y1 and P2Y12\/thrombin in ADP- and thrombin-induced human platelet activation. Br J Pharmacol 142, 1325\u20131331, https:\/\/doi.org\/10.1038\/sj.bjp.0705885 (2004).","journal-title":"Br J Pharmacol"},{"key":"26577_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1161\/ATVBAHA.115.306885","volume":"36","author":"T Gremmel","year":"2016","unstructured":"Gremmel, T. et al. Synergistic Inhibition of Both P2Y(1) and P2Y(12) Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis. Arterioscl Throm Vas 36, 501\u2013509, https:\/\/doi.org\/10.1161\/Atvbaha.115.306885 (2016).","journal-title":"Arterioscl Throm Vas"},{"key":"26577_CR19","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott, S. D. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357, 2001\u20132015, https:\/\/doi.org\/10.1056\/NEJMoa0706482 (2007).","journal-title":"N Engl J Med"},{"key":"26577_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin, L. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361, 1045\u20131057, https:\/\/doi.org\/10.1056\/NEJMoa0904327 (2009).","journal-title":"N Engl J Med"},{"key":"26577_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature13288","volume":"509","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Agonist-bound structure of the human P2Y12 receptor. Nature 509, 119\u2013122, https:\/\/doi.org\/10.1038\/nature13288 (2014).","journal-title":"Nature"},{"key":"26577_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature13083","volume":"509","author":"K Zhang","year":"2014","unstructured":"Zhang, K. et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509, 115\u2013118, https:\/\/doi.org\/10.1038\/nature13083 (2014).","journal-title":"Nature"},{"key":"26577_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14287","volume":"520","author":"D Zhang","year":"2015","unstructured":"Zhang, D. et al. Two disparate ligand-binding sites in the human P2Y1 receptor. Nature 520, 317\u2013321, https:\/\/doi.org\/10.1038\/nature14287 (2015).","journal-title":"Nature"},{"key":"26577_CR24","doi-asserted-by":"publisher","first-page":"E5675","DOI":"10.1073\/pnas.1612353113","volume":"113","author":"Y Miao","year":"2016","unstructured":"Miao, Y. et al. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor. Proc Natl Acad Sci USA 113, E5675\u20135684, https:\/\/doi.org\/10.1073\/pnas.1612353113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"26577_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1021\/jm070759m","volume":"51","author":"CN Cavasotto","year":"2008","unstructured":"Cavasotto, C. N. et al. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. Journal of Medicinal Chemistry 51, 581\u2013588, https:\/\/doi.org\/10.1021\/jm070759m (2008).","journal-title":"Journal of Medicinal Chemistry"},{"key":"26577_CR26","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/prot.23012","volume":"79","author":"SK Kim","year":"2011","unstructured":"Kim, S. K. et al. Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor. Proteins 79, 1878\u20131897, https:\/\/doi.org\/10.1002\/prot.23012 (2011).","journal-title":"Proteins"},{"key":"26577_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrd2518","volume":"7","author":"MC Lagerstrom","year":"2008","unstructured":"Lagerstrom, M. C. & Schioth, H. B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7, 339\u2013357, https:\/\/doi.org\/10.1038\/nrd2518 (2008).","journal-title":"Nat Rev Drug Discov"},{"key":"26577_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/nature23272","author":"T Hua","year":"2017","unstructured":"Hua, T. et al. Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature. https:\/\/doi.org\/10.1038\/nature23272 (2017).","journal-title":"Nature"},{"key":"26577_CR29","unstructured":"Schr\u00f6dinger Induced Fit Docking Protocol 2015-4, Glide version 6.4, Prime version 3.7 (Schr\u00f6dinger, LLC) (2015b)."},{"key":"26577_CR30","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.2147\/IJN.S91316","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis. Int J Nanomedicine 10, 6905\u20136918, https:\/\/doi.org\/10.2147\/IJN.S91316 (2015).","journal-title":"Int J Nanomedicine"},{"key":"26577_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1124\/mol.117.109660","volume":"92","author":"ZG Gao","year":"2017","unstructured":"Gao, Z. G. & Jacobson, K. A. Distinct Signaling Patterns of Allosteric Antagonism at the P2Y1 Receptor. Mol Pharmacol 92, 613\u2013626, https:\/\/doi.org\/10.1124\/mol.117.109660 (2017).","journal-title":"Mol Pharmacol"},{"key":"26577_CR32","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1021\/acs.jmedchem.5b02008","volume":"59","author":"JJ Irwin","year":"2016","unstructured":"Irwin, J. J. & Shoichet, B. K. Docking Screens for Novel Ligands Conferring New Biology. J Med Chem 59, 4103\u20134120, https:\/\/doi.org\/10.1021\/acs.jmedchem.5b02008 (2016).","journal-title":"J Med Chem"},{"key":"26577_CR33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1021\/cb5009487","volume":"10","author":"D Duan","year":"2015","unstructured":"Duan, D., Doak, A. K., Nedyalkova, L. & Shoichet, B. K. Colloidal aggregation and the in vitro activity of traditional Chinese medicines. ACS Chem Biol 10, 978\u2013988, https:\/\/doi.org\/10.1021\/cb5009487 (2015).","journal-title":"ACS Chem Biol"},{"key":"26577_CR34","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1021\/jm0340896","volume":"46","author":"AJ Ryan","year":"2003","unstructured":"Ryan, A. J., Gray, N. M., Lowe, P. N. & Chung, C. W. Effect of detergent on \u201cpromiscuous\u201d inhibitors. J Med Chem 46, 3448\u20133451, https:\/\/doi.org\/10.1021\/jm0340896 (2003).","journal-title":"J Med Chem"},{"key":"26577_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fphar.2017.00361","volume":"8","author":"T Zhao","year":"2017","unstructured":"Zhao, T. et al. Specific Combination of Salvianolic Acids As Core Active Ingredients of Danhong Injection for Treatment of Arterial Thrombosis and Its Derived Dry Gangrene. Front Pharmacol 8, 361, https:\/\/doi.org\/10.3389\/fphar.2017.00361 (2017).","journal-title":"Front Pharmacol"},{"key":"26577_CR36","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1021\/cb500086e","volume":"9","author":"HI Ingolfsson","year":"2014","unstructured":"Ingolfsson, H. I. et al. Phytochemicals perturb membranes and promiscuously alter protein function. ACS Chem Biol 9, 1788\u20131798, https:\/\/doi.org\/10.1021\/cb500086e (2014).","journal-title":"ACS Chem Biol"},{"key":"26577_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature11691","volume":"492","author":"J Besnard","year":"2012","unstructured":"Besnard, J. et al. Automated design of ligands to polypharmacological profiles. Nature 492, 215\u2013220, https:\/\/doi.org\/10.1038\/nature11691 (2012).","journal-title":"Nature"},{"key":"26577_CR38","doi-asserted-by":"crossref","unstructured":"Ballesteros, J. A. & Weinstein, H. In Methods in Neurosciences Vol. 25 (ed. Sealfon Stuart, C.) 366\u2013428 (Academic Press, 1995).","DOI":"10.1016\/S1043-9471(05)80049-7"},{"key":"26577_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ahj.2014.06.014","volume":"168","author":"K Huber","year":"2014","unstructured":"Huber, K. et al. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? Am Heart J 168, 611\u2013621, https:\/\/doi.org\/10.1016\/j.ahj.2014.06.014 (2014).","journal-title":"Am Heart J"},{"key":"26577_CR40","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2174\/1381612822666161010105242","volume":"23","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases. Curr Pharm Des 23, 1077\u20131097, https:\/\/doi.org\/10.2174\/1381612822666161010105242 (2017).","journal-title":"Curr Pharm Des"},{"key":"26577_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2210-10-10","volume":"10","author":"B Jiang","year":"2010","unstructured":"Jiang, B. et al. Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling. BMC Pharmacol 10, 10, https:\/\/doi.org\/10.1186\/1471-2210-10-10 (2010).","journal-title":"BMC Pharmacol"},{"key":"26577_CR42","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1016\/j.bmcl.2009.04.083","volume":"19","author":"B Sperl","year":"2009","unstructured":"Sperl, B., Seifert, M. H. & Berg, T. Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains. Bioorg Med Chem Lett 19, 3305\u20133309, https:\/\/doi.org\/10.1016\/j.bmcl.2009.04.083 (2009).","journal-title":"Bioorg Med Chem Lett"},{"key":"26577_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/1087057109359686","volume":"15","author":"L Wang","year":"2010","unstructured":"Wang, L. et al. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay. J Biomol Screen 15, 239\u2013250, https:\/\/doi.org\/10.1177\/1087057109359686 (2010).","journal-title":"J Biomol Screen"},{"key":"26577_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1021\/acschembio.7b00903","volume":"13","author":"JB Baell","year":"2018","unstructured":"Baell, J. B. & Nissink, J. W. M. Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations. ACS Chem Biol 13, 36\u201344, https:\/\/doi.org\/10.1021\/acschembio.7b00903 (2018).","journal-title":"ACS Chem Biol"},{"key":"26577_CR45","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1039\/c2mb00002d","volume":"8","author":"X Chen","year":"2012","unstructured":"Chen, X., Liu, M. X. & Yan, G. Y. Drug-target interaction prediction by random walk on the heterogeneous network. Mol Biosyst 8, 1970\u20131978, https:\/\/doi.org\/10.1039\/c2mb00002d (2012).","journal-title":"Mol Biosyst"},{"key":"26577_CR46","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/bib\/bbv066","volume":"17","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Drug-target interaction prediction: databases, web servers and computational models. Brief Bioinform 17, 696\u2013712, https:\/\/doi.org\/10.1093\/bib\/bbv066 (2016).","journal-title":"Brief Bioinform"},{"key":"26577_CR47","doi-asserted-by":"publisher","first-page":"e1004975","DOI":"10.1371\/journal.pcbi.1004975","volume":"12","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning. PLoS Comput Biol 12, e1004975, https:\/\/doi.org\/10.1371\/journal.pcbi.1004975 (2016).","journal-title":"PLoS Comput Biol"},{"key":"26577_CR48","unstructured":"Schr\u00f6dinger Glide, version 6.9 (Schr\u00f6dinger, LLC) (2015a)."},{"key":"26577_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1-2","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132, 19\u201325, https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","journal-title":"SoftwareX"},{"key":"26577_CR50","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","volume":"35","author":"EL Wu","year":"2014","unstructured":"Wu, E. L. et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations. J Comput Chem 35, 1997\u20132004, https:\/\/doi.org\/10.1002\/jcc.23702 (2014).","journal-title":"J Comput Chem"},{"key":"26577_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field. J Chem Theory Comput 12, 405\u2013413, https:\/\/doi.org\/10.1021\/acs.jctc.5b00935 (2016).","journal-title":"J Chem Theory Comput"},{"key":"26577_CR52","unstructured":"Traditional Chinese Medicine Database (TCMdb), Neotrident Co., Ltd., Beijing, Chinese edition, 2011."},{"key":"26577_CR53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder, E. et al. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. J Chem Theory Comput 12, 281\u2013296, https:\/\/doi.org\/10.1021\/acs.jctc.5b00864 (2016).","journal-title":"J Chem Theory Comput"},{"key":"26577_CR54","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47, 1739\u20131749, https:\/\/doi.org\/10.1021\/jm0306430 (2004).","journal-title":"J Med Chem"},{"key":"26577_CR55","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49, 6177\u20136196, https:\/\/doi.org\/10.1021\/jm051256o (2006).","journal-title":"J Med Chem"},{"key":"26577_CR56","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren, T. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47, 1750\u20131759, https:\/\/doi.org\/10.1021\/jm030644s (2004).","journal-title":"J Med Chem"},{"key":"26577_CR57","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","volume":"14","author":"R Farid","year":"2006","unstructured":"Farid, R., Day, T., Friesner, R. A. & Pearlstein, R. A. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorgan Med Chem 14, 3160\u20133173, https:\/\/doi.org\/10.1016\/j.bmc.2005.12.032 (2006).","journal-title":"Bioorgan Med Chem"},{"key":"26577_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","volume":"67","author":"W Sherman","year":"2006","unstructured":"Sherman, W., Beard, H. S. & Farid, R. Use of an induced fit receptor structure in virtual screening. Chem Biol Drug Des 67, 83\u201384, https:\/\/doi.org\/10.1111\/j.1747-0285.2005.00327.x (2006).","journal-title":"Chem Biol Drug Des"},{"key":"26577_CR59","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/jm050540c","volume":"49","author":"W Sherman","year":"2006","unstructured":"Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A. & Farid, R. Novel procedure for modeling ligand\/receptor induced fit effects. J Med Chem 49, 534\u2013553, https:\/\/doi.org\/10.1021\/jm050540c (2006).","journal-title":"J Med Chem"},{"key":"26577_CR60","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1124\/jpet.110.173005","volume":"335","author":"JD Violin","year":"2010","unstructured":"Violin, J. D. et al. Selectively engaging beta-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance. J Pharmacol Exp Ther 335, 572\u2013579, https:\/\/doi.org\/10.1124\/jpet.110.173005 (2010).","journal-title":"J Pharmacol Exp Ther"},{"key":"26577_CR61","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1124\/mol.111.072801","volume":"80","author":"S Rajagopal","year":"2011","unstructured":"Rajagopal, S. et al. Quantifying Ligand Bias at Seven-Transmembrane Receptors. Mol Pharmacol 80, 367\u2013377, https:\/\/doi.org\/10.1124\/mol.111.072801 (2011).","journal-title":"Mol Pharmacol"}],"updated-by":[{"DOI":"10.1038\/s41598-018-29406-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26577-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26577-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26577-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:35:27Z","timestamp":1671600927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26577-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26577"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26577-0","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-018-29406-6","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.C.S. is a founder and board member of Bird Rock Bio, a company focuses on GPCR therapeutic antibodies. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8084"}}